BN Business News
Add your company to Business Communicator →

Business · 16/06/2025Updated: 10/17/2026 · 1 min read

FDA Announces Public Advisory Committee Meeting for Belantamab Mafodotin BLA 761440

Summary

The FDA is hosting a public meeting of the Oncologic Drugs Advisory Committee to discuss the biologic license application for Belantamab Mafodotin, and is seeking public comments on the matter.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →